366 related articles for article (PubMed ID: 20478588)
21. [Exposure to endocrine disrupting chemicals and human health: a review of epidemiological studies focused on hypospadias and cryptorchidism].
Kurahashi N; Kasai S; Saijo Y; Sata F; Kishi R
Nihon Eiseigaku Zasshi; 2005 Jan; 60(1):15-22. PubMed ID: 15773293
[TBL] [Abstract][Full Text] [Related]
22. Maternal exposures to endocrine disrupting chemicals and hypospadias in offspring.
Giordano F; Abballe A; De Felip E; di Domenico A; Ferro F; Grammatico P; Ingelido AM; Marra V; Marrocco G; Vallasciani S; Figà-Talamanca I
Birth Defects Res A Clin Mol Teratol; 2010 Apr; 88(4):241-50. PubMed ID: 20196143
[TBL] [Abstract][Full Text] [Related]
23. Parental occupational exposure to potential endocrine disrupting chemicals and risk of hypospadias in infants.
Nassar N; Abeywardana P; Barker A; Bower C
Occup Environ Med; 2010 Sep; 67(9):585-9. PubMed ID: 19939854
[TBL] [Abstract][Full Text] [Related]
24. Genital anomalies in boys and the environment.
Main KM; Skakkebaek NE; Virtanen HE; Toppari J
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):279-89. PubMed ID: 20541152
[TBL] [Abstract][Full Text] [Related]
25. [Environmental pollutants in maternal milk and cryptorchidism].
Brucker-Davis F; Ducot B; Wagner-Mahler K; Tommasi C; Ferrari P; Pacini P; Boda-Buccino M; Bongain A; Azuar P; Fénichel P
Gynecol Obstet Fertil; 2008 Sep; 36(9):840-7. PubMed ID: 18707911
[TBL] [Abstract][Full Text] [Related]
26. Hypospadias rates in new york state are not increasing.
Fisch H; Lambert SM; Hensle TW; Hyun G
J Urol; 2009 May; 181(5):2291-4. PubMed ID: 19303092
[TBL] [Abstract][Full Text] [Related]
27. [Exposure to endocrine disruptors and male urogenital tract malformations [cryptorchidism and hypospadias]].
Fernández MF; Olmos B; Olea N
Gac Sanit; 2007; 21(6):500-14. PubMed ID: 18001666
[TBL] [Abstract][Full Text] [Related]
28. Temporal decline of sperm concentration: role of endocrine disruptors.
Cannarella R; Gül M; Rambhatla A; Agarwal A
Endocrine; 2023 Jan; 79(1):1-16. PubMed ID: 36194343
[TBL] [Abstract][Full Text] [Related]
29. What is new in cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis.
Thorup J; McLachlan R; Cortes D; Nation TR; Balic A; Southwell BR; Hutson JM
J Pediatr Surg; 2010 Oct; 45(10):2074-86. PubMed ID: 20920735
[TBL] [Abstract][Full Text] [Related]
30. Environmental factors and semen quality.
Jurewicz J; Hanke W; Radwan M; Bonde JP
Int J Occup Med Environ Health; 2009; 22(4):305-29. PubMed ID: 20053623
[TBL] [Abstract][Full Text] [Related]
31. International geographic correlation study of the prevalence of disorders of male reproductive health.
Serrano T; Chevrier C; Multigner L; Cordier S; Jégou B
Hum Reprod; 2013 Jul; 28(7):1974-86. PubMed ID: 23670171
[TBL] [Abstract][Full Text] [Related]
32. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.
Rodprasert W; Toppari J; Virtanen HE
Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for hypospadias in Norwegian boys - association with testicular dysgenesis syndrome?
Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
Int J Androl; 2004 Aug; 27(4):213-21. PubMed ID: 15271200
[TBL] [Abstract][Full Text] [Related]
34. Possible effects of endocrine disruptors on male reproductive function.
Mori C
Kaibogaku Zasshi; 2001 Aug; 76(4):361-8. PubMed ID: 11577437
[TBL] [Abstract][Full Text] [Related]
35. Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries.
Toppari J; Haavisto AM; Alanen M
Cad Saude Publica; 2002; 18(2):413-20. PubMed ID: 11923882
[TBL] [Abstract][Full Text] [Related]
36. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome.
Fisher JS
Reproduction; 2004 Mar; 127(3):305-15. PubMed ID: 15016950
[TBL] [Abstract][Full Text] [Related]
37. Is Hypospadias Associated with Prenatal Exposure to Endocrine Disruptors? A French Collaborative Controlled Study of a Cohort of 300 Consecutive Children Without Genetic Defect.
Kalfa N; Paris F; Philibert P; Orsini M; Broussous S; Fauconnet-Servant N; Audran F; Gaspari L; Lehors H; Haddad M; Guys JM; Reynaud R; Alessandrini P; Merrot T; Wagner K; Kurzenne JY; Bastiani F; Bréaud J; Valla JS; Lacombe GM; Dobremez E; Zahhaf A; Daures JP; Sultan C
Eur Urol; 2015 Dec; 68(6):1023-30. PubMed ID: 26007639
[TBL] [Abstract][Full Text] [Related]
38. The Male Reproductive System and Endocrine Disruptors.
Schiesaro MG; Amato AML; Maneschi C; Sciabica V; Pigatto E; Sanna M
Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):686-703. PubMed ID: 34607552
[TBL] [Abstract][Full Text] [Related]
39. Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction.
Norgil Damgaard I; Main KM; Toppari J; Skakkebaek NE
Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):289-309. PubMed ID: 12064894
[TBL] [Abstract][Full Text] [Related]
40. Ethnic differences in occurrence of TDS-- genetics and/or environment?
Giwercman A; Rylander L; Hagmar L; Giwercman YL
Int J Androl; 2006 Feb; 29(1):291-7; discussion 304-6. PubMed ID: 16466550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
